| Barbara L Starry, NP | |
|
1316 E 7th St, Suite 3, Auburn, IN 46706-2538 | |
| (260) 432-4400 | |
| (260) 969-6898 |
| Full Name | Barbara L Starry |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 17 Years |
| Location | 1316 E 7th St, Auburn, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306033683 | NPI | - | NPPES |
| 200889920 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 71002604A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Regional Medical Center | Fort wayne, IN | Hospital |
| Community Memorial Hospital | Hicksville, OH | Hospital |
| Parkview Noble Hospital | Kendallville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rp Care Llc | 9234424813 | 35 |
News Archive
A new technique for increasing the survival rates of human embryonic stem cells will revolutionize their use in drug discovery and therapy. Human embryonic stem cells often die during the process of isolation using enzymatic disaggregation or low-density plating, which limits their usefulness in drug discovery and basic research. Similarly, the low rate of attachment of implanted cells hinders cell therapy.
A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.
Global food insecurity that has left almost one billion people hungry could become a "permanent disaster" and endanger millions of lives, former U.N. secretary-general Kofi Annan said, Bloomberg reports.
The Leukemia & Lymphoma Society applauds the FDA's recent approval of two new drugs - daratumumab and ixazomib - to treat patients with relapsed multiple myeloma. These therapies are the latest in a growing arsenal to fight this blood cancer that impacts nearly 100,000 patients in the U.S. Advances in treatments for many different types of blood cancers are happening with dizzying speed and these two approvals in just one week are the latest evidence of this phenomenon.
› Verified 2 days ago
| Entity Name | Rp Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134570104 PECOS PAC ID: 9234424813 Enrollment ID: O20160822000852 |
News Archive
A new technique for increasing the survival rates of human embryonic stem cells will revolutionize their use in drug discovery and therapy. Human embryonic stem cells often die during the process of isolation using enzymatic disaggregation or low-density plating, which limits their usefulness in drug discovery and basic research. Similarly, the low rate of attachment of implanted cells hinders cell therapy.
A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.
Global food insecurity that has left almost one billion people hungry could become a "permanent disaster" and endanger millions of lives, former U.N. secretary-general Kofi Annan said, Bloomberg reports.
The Leukemia & Lymphoma Society applauds the FDA's recent approval of two new drugs - daratumumab and ixazomib - to treat patients with relapsed multiple myeloma. These therapies are the latest in a growing arsenal to fight this blood cancer that impacts nearly 100,000 patients in the U.S. Advances in treatments for many different types of blood cancers are happening with dizzying speed and these two approvals in just one week are the latest evidence of this phenomenon.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara L Starry, NP 2518 E Dupont Rd, Fort Wayne, IN 46825-1675 Ph: (260) 432-4400 | Barbara L Starry, NP 1316 E 7th St, Suite 3, Auburn, IN 46706-2538 Ph: (260) 432-4400 |
News Archive
A new technique for increasing the survival rates of human embryonic stem cells will revolutionize their use in drug discovery and therapy. Human embryonic stem cells often die during the process of isolation using enzymatic disaggregation or low-density plating, which limits their usefulness in drug discovery and basic research. Similarly, the low rate of attachment of implanted cells hinders cell therapy.
A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.
Global food insecurity that has left almost one billion people hungry could become a "permanent disaster" and endanger millions of lives, former U.N. secretary-general Kofi Annan said, Bloomberg reports.
The Leukemia & Lymphoma Society applauds the FDA's recent approval of two new drugs - daratumumab and ixazomib - to treat patients with relapsed multiple myeloma. These therapies are the latest in a growing arsenal to fight this blood cancer that impacts nearly 100,000 patients in the U.S. Advances in treatments for many different types of blood cancers are happening with dizzying speed and these two approvals in just one week are the latest evidence of this phenomenon.
› Verified 2 days ago
Nicole M Sanderson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 510 Smaltz Way, Auburn, IN 46706 Phone: 260-927-1756 Fax: 260-479-4639 | |
Mrs. Jamie Lynn Starkey, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1310 E 7th St Ste J, Auburn, IN 46706 Phone: 260-925-0305 Fax: 260-925-6041 | |
Ms. Tabitha Pittman, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1314 E 7th St Ste 102, Auburn, IN 46706 Phone: 260-927-5045 Fax: 260-927-5047 | |
Lyndi A Bienz, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1316 E 7th St Ste 4, Auburn, IN 46706 Phone: 260-920-2000 Fax: 260-920-3623 | |
Angela Webb, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1316 E 7th St Ste 4, Auburn, IN 46706 Phone: 260-920-2000 | |
Jessica L Slattery, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1306 E 7th St Ste A, Auburn, IN 46706 Phone: 260-925-1255 Fax: 260-925-1256 | |
Angela Lynn Schroeder, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1310 E 7th St Ste K, Auburn, IN 46706 Phone: 260-925-3500 Fax: 260-925-3195 |